~~<i id='3D13B950B7'><strike id='3D13B950B7'><tt id='3D13B950B7'><pre id='3D13B950B7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：fashion 2025-08-11 09:49:09 - browse：7

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA early review: GLP

explore

focus

hotspot

focus

knowledge

IsnoonesafefromtheFTC?HasPfizerbottomedout?Andisbiotechfinallyback?Wecoverallthatandmorethisweekon“T

WSS

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New Medicare drug pricing powers could soon be upended in court

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Generative AI mines health records to identify patients’ social needs

Heart disease and mental health: A look at cardiac psychology

explore

explore

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Nonprofit, backed by Microsoft, to certify AI tools in health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Heart attack and stroke risk calculators need revising

Health and fitness trackers are measuring the wrong things

After affirmative action ruling, medical educators look to 'holistic review'

JPM pitch from hospitals? Revenue streams outside of patient care

How to save PrEP access — and even expand it

At JPM 2024, hospital systems pitch financial strength to investors

focus

American taxpayers paid $1.8 trillion in health care costs in 2022

DeSantis can now import cheaper drugs. But will Biden get credit?

The SUPPORT Act is critical to fighting the opioid crisis

At JPM 2024, hospital systems pitch financial strength to investors

Merck to acquire Harpoon Therapeutics for $680 million

Fauci's latest grilling in Congress: 9 hours, behind closed doors

hotspot

focus

focus

knowledge